Project description
Continuous biosensing goes beyond glucose for better personal monitoring
The composition of blood is typically evaluated with blood tests, to reveal abnormalities associated with diseases or metabolism as well as changes related to ageing or menopause. For some time, diabetics have benefitted from continuous glucose monitoring (CGM) via a tiny sensor under the skin that reports glucose levels in real time. CGM has minimised the need for repetitive blood tests while enhancing the temporal resolution of changes, altering the course of the disease for many. The EU-funded CONSENSE project is now developing new sensor technologies suited for measuring a wealth of other biomolecules that are critical to health status, for truly personalised medicine and better outcomes.
Fields of science
- engineering and technologyenvironmental biotechnologybiosensing
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteins
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensors
- engineering and technologyother engineering and technologiesmicrotechnologymolecular engineering
Programme(s)
Funding Scheme
MSCA-ITN-ETN - European Training NetworksCoordinator
5612 AE Eindhoven
Netherlands
See on map
Participants (9)
8000 Aarhus C
See on map
1015 Lausanne
See on map
7610001 Rehovot
See on map
3000 Leuven
See on map
80539 Munchen
See on map
Participation ended
6525 XZ Nijmegen
See on map
3590 Diepenbeek
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
5612 AZ Eindhoven
See on map
6525 GA Nijmegen
See on map